Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

NCT01415531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

641

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Nebivolol
DRUG: Placebo

Sponsor

Forest Laboratories